The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rothstein, D. M.
Right arrow Articles by Morimoto, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rothstein, D. M.
Right arrow Articles by Morimoto, C.

The Journal of Immunology, Vol 146, Issue 4 1175-1183, Copyright © 1991 by American Association of Immunologists


ARTICLES

Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line

DM Rothstein, A Yamada, SF Schlossman and C Morimoto
Division of Tumor Immunology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA 02115.

The CD45 Ag family is comprised of at least five isoforms generated by the alternative splicing of three exons encoded by a single leukocyte common Ag gene. These isoforms, differentially expressed on subsets of T cells, are widely believed to delineate maturational status. Thus, cells expressing the high molecular mass CD45RA+ isoforms (220 and 205 kDa) are believed to represent naive cells, whereas those lacking CD45RA and expressing high density CD45RO (180 kDa) represent memory cells. This is based on findings that after activation, CD45RA+ cells "convert" to the CD45RA- phenotype, losing CD45RA and gaining CD45RO. This conversion is believed to be both unidirectional and irreversible. We now report a strategy for the development of polyclonal CD45RA+ cell lines derived from peripheral blood CD4+CD45RA+ cells. However, in such cell lines, CD45RA expression was not constant, but varied cyclically with restimulation. After restimulation, CD45RA expression decreased significantly, nadiring on days 5 to 7. However, CD45RA was fully re- expressed by days 14 to 16. These cells coexpressed high density CD45RO, which did not vary through the stimulatory cycle. Cells sorted CD45RA- on day 7 of the cycle rapidly reexpress CD45RA. Metabolic labeling revealed that the 220 kDa CD45RA isoform is no longer synthesized. Synthesis of the 205 kDa (CD45RA) isoform decreased significantly early after stimulation, but then increased back to baseline after day 12. The 180-kDa (CD45RO) isoform followed an opposite pattern. Our results document that alternative splicing of the different CD45 isoforms is highly regulated after activation and that conversion from CD45RA+ to CD45RA- is neither unidirectional, nor irreversible.


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
S. Gregori, P. Mangia, R. Bacchetta, E. Tresoldi, F. Kolbinger, C. Traversari, J. M. Carballido, J. E. de Vries, U. Korthauer, and M.-G. Roncarolo
An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells
J. Exp. Med., April 18, 2005; 201(8): 1293 - 1305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sarzotti, D. D. Patel, X. Li, D. A. Ozaki, S. Cao, S. Langdon, R. E. Parrott, K. Coyne, and R. H. Buckley
T Cell Repertoire Development in Humans with SCID After Nonablative Allogeneic Marrow Transplantation
J. Immunol., March 1, 2003; 170(5): 2711 - 2718.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. A. Robichaud, B. Barbeau, J.-F. Fortin, D. M. Rothstein, and M. J. Tremblay
Nuclear Factor of Activated T Cells Is a Driving Force for Preferential Productive HIV-1 Infection of CD45RO-expressing CD4+ T Cells
J. Biol. Chem., June 21, 2002; 277(26): 23733 - 23741.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. R. Dunbar, C. L. Smith, D. Chao, M. Salio, D. Shepherd, F. Mirza, M. Lipp, A. Lanzavecchia, F. Sallusto, A. Evans, et al.
A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response
J. Immunol., December 1, 2000; 165(11): 6644 - 6652.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Muraro, M. Pette, B. Bielekova, H. F. McFarland, and R. Martin
Human Autoreactive CD4+ T Cells from Naive CD45RA+ and Memory CD45RO+ Subsets Differ with Respect to Epitope Specificity and Functional Antigen Avidity
J. Immunol., May 15, 2000; 164(10): 5474 - 5481.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. F. Fagnoni, R. Vescovini, G. Passeri, G. Bologna, M. Pedrazzoni, G. Lavagetto, A. Casti, C. Franceschi, M. Passeri, and P. Sansoni
Shortage of circulating naive CD8+ T cells provides new insights on immunodeficiency in aging
Blood, May 1, 2000; 95(9): 2860 - 2868.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. Hubert, F. Bergeron, V. Ferreira, M. Seligmann, E. Oksenhendler, P. Debre, and B. Autran
Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia
Int. Immunol., April 1, 2000; 12(4): 449 - 457.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Andersen and B. Smedegaard
CD4+ T-Cell Subsets That Mediate Immunological Memory to Mycobacterium tuberculosis Infection in Mice
Infect. Immun., February 1, 2000; 68(2): 621 - 629.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. W. Lynch and A. Weiss
A Model System for Activation-Induced Alternative Splicing of CD45 Pre-mRNA in T Cells Implicates Protein Kinase C and Ras
Mol. Cell. Biol., January 1, 2000; 20(1): 70 - 80.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
C. A. London, M. P. Lodge, and A. K. Abbas
Functional Responses and Costimulator Dependence of Memory CD4+ T Cells
J. Immunol., January 1, 2000; 164(1): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. J. Pittet, D. Valmori, P. R. Dunbar, D. E. Speiser, D. Lienard, F. Lejeune, K. Fleischhauer, V. Cerundolo, J.-C. Cerottini, and P. Romero
High Frequencies of Naive Melan-A/MART-1–specific CD8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (HLA)-A2 Individuals
J. Exp. Med., September 6, 1999; 190(5): 705 - 716.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Z. GAO, R. ZHONG, J. JIANG, B. GARCIA, J. J. XING, M. J. WHITE, and A. I. LAZAROVITS
Adoptively Transferable Tolerance Induced by CD45RB Monoclonal Antibody
J. Am. Soc. Nephrol., February 1, 1999; 10(2): 374 - 381.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. P. Basadonna, L. Auersvald, C. Q. Khuong, X. X. Zheng, N. Kashio, D. Zekzer, M. Minozzo, H.-Y. Qian, L. Visser, A. Diepstra, et al.
Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy
PNAS, March 31, 1998; 95(7): 3821 - 3826.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Bunce and E. B. Bell
CD45RC Isoforms Define Two Types of CD4 Memory T Cells, One of which Depends on Persisting Antigen
J. Exp. Med., February 17, 1997; 185(4): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Stuhler and S. F. Schlossman
Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets
PNAS, January 21, 1997; 94(2): 622 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Onodera, D. G. Motto, G. A. Koretzky, and D. M. Rothstein
Differential Regulation of Activation-induced Tyrosine Phosphorylation and Recruitment of SLP-76 to Vav by Distinct Isoforms of the CD45 Protein-tyrosine Phosphatase
J. Biol. Chem., September 6, 1996; 271(36): 22225 - 22230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. W. McKenney, H. Onodera, L. Gorman, T. Mimura, and D. M. Rothstein
Distinct Isoforms of the CD45 Protein-tyrosine Phosphatase Differentially Regulate Interleukin 2 Secretion and Activation Signal Pathways Involving Vav in T Cells
J. Biol. Chem., October 20, 1995; 270(42): 24949 - 24954.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.